Trial Outcomes & Findings for Impact of Prevnar 13 on Ear Infections in Children (NCT NCT01272999)
NCT ID: NCT01272999
Last Updated: 2023-05-23
Results Overview
The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 1 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95 percent (%) confidence interval (CI) based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this outcome measure (OM).
Recruitment status
COMPLETED
Target enrollment
391 participants
Primary outcome timeframe
Surveillance Year 1
Results posted on
2023-05-23
Participant Flow
This study is a 3-year prospective laboratory-based surveillance study wherein the results of the samples obtained were summarized separately for each year. In this study, no more than 1 sample was obtained from a participant and no more than 1 serotype was isolated from any sample.
Participant milestones
| Measure |
MEF Population
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
Mastoid Population
Participants with S pneumoniae isolates from mastoid sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|---|
|
Overall Study
STARTED
|
357
|
34
|
|
Overall Study
COMPLETED
|
357
|
34
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Impact of Prevnar 13 on Ear Infections in Children
Baseline characteristics by cohort
| Measure |
MEF Population
n=357 Participants
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
Mastoid Population
n=34 Participants
Participants with S pneumoniae isolates from mastoid sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
Total
n=391 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
28.7 months
STANDARD_DEVIATION 26.0 • n=93 Participants
|
35.5 months
STANDARD_DEVIATION 47.2 • n=4 Participants
|
29.3 months
STANDARD_DEVIATION 28.5 • n=27 Participants
|
|
Sex/Gender, Customized
Female
|
144 Participants
n=93 Participants
|
18 Participants
n=4 Participants
|
162 Participants
n=27 Participants
|
|
Sex/Gender, Customized
Male
|
209 Participants
n=93 Participants
|
16 Participants
n=4 Participants
|
225 Participants
n=27 Participants
|
|
Sex/Gender, Customized
Not collected
|
4 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
4 Participants
n=27 Participants
|
PRIMARY outcome
Timeframe: Surveillance Year 1Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 1 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95 percent (%) confidence interval (CI) based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this outcome measure (OM).
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype included in Prevnar 13:7F
|
0.7 percentage of isolates
Interval 0.0 to 4.1
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype included in Prevnar 13:19F
|
2.2 percentage of isolates
Interval 0.5 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:15B
|
4.4 percentage of isolates
Interval 1.6 to 9.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:16
|
1.5 percentage of isolates
Interval 0.2 to 5.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:13
|
0.7 percentage of isolates
Interval 0.0 to 4.1
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:15A
|
3.7 percentage of isolates
Interval 1.2 to 8.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:15C
|
3.7 percentage of isolates
Interval 1.2 to 8.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:15F
|
0.0 percentage of isolates
Interval 0.0 to 2.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:17
|
0.0 percentage of isolates
Interval 0.0 to 2.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:20
|
0.0 percentage of isolates
Interval 0.0 to 2.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:21
|
3.0 percentage of isolates
Interval 0.8 to 7.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:22F
|
1.5 percentage of isolates
Interval 0.2 to 5.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:23A
|
3.7 percentage of isolates
Interval 1.2 to 8.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:23B
|
2.2 percentage of isolates
Interval 0.5 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:31
|
2.2 percentage of isolates
Interval 0.5 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:33A
|
0.7 percentage of isolates
Interval 0.0 to 4.1
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:33F
|
3.0 percentage of isolates
Interval 0.8 to 7.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:34
|
0.0 percentage of isolates
Interval 0.0 to 2.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:35B
|
6.7 percentage of isolates
Interval 3.1 to 12.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:35F
|
0.0 percentage of isolates
Interval 0.0 to 2.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:38
|
0.7 percentage of isolates
Interval 0.0 to 4.1
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Total Serotype not included in Prevnar 13
|
56.3 percentage of isolates
Interval 47.5 to 64.8
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype clumps
|
1.5 percentage of isolates
Interval 0.2 to 5.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype Missing/non-viable
|
1.5 percentage of isolates
Interval 0.2 to 5.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype included in Prevnar 13:3
|
5.9 percentage of isolates
Interval 2.6 to 11.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype included in Prevnar 13:19A
|
31.9 percentage of isolates
Interval 24.1 to 40.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Total Serotype included in Prevnar 13
|
40.7 percentage of isolates
Interval 32.4 to 49.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:6C
|
6.7 percentage of isolates
Interval 3.1 to 12.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:7C
|
1.5 percentage of isolates
Interval 0.2 to 5.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:9N
|
2.2 percentage of isolates
Interval 0.5 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:10
|
3.7 percentage of isolates
Interval 1.2 to 8.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:11
|
3.7 percentage of isolates
Interval 1.2 to 8.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:12
|
0.7 percentage of isolates
Interval 0.0 to 4.1
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
Serotype not included in Prevnar 13:12F
|
0.0 percentage of isolates
Interval 0.0 to 2.7
|
PRIMARY outcome
Timeframe: Surveillance Year 2Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 2 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=111 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:33A
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype included in Prevnar 13:3
|
6.3 percentage of isolates
Interval 2.6 to 12.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype included in Prevnar 13:7F
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype included in Prevnar 13:19A
|
23.4 percentage of isolates
Interval 15.9 to 32.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype included in Prevnar 13:19F
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Total Serotype included in Prevnar 13
|
31.5 percentage of isolates
Interval 23.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:6C
|
4.5 percentage of isolates
Interval 1.5 to 10.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:7C
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:9N
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:10
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:11
|
7.2 percentage of isolates
Interval 3.2 to 13.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:12
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:12F
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:13
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:15A
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:15B
|
4.5 percentage of isolates
Interval 1.5 to 10.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:15C
|
2.7 percentage of isolates
Interval 0.6 to 7.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:15F
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:16
|
2.7 percentage of isolates
Interval 0.6 to 7.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:17
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:20
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:21
|
9.0 percentage of isolates
Interval 4.4 to 15.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:22F
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:23A
|
4.5 percentage of isolates
Interval 1.5 to 10.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:23B
|
7.2 percentage of isolates
Interval 3.2 to 13.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:31
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:33F
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:34
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:35B
|
13.5 percentage of isolates
Interval 7.8 to 21.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:35F
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype not included in Prevnar 13:38
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Total Serotype not included in Prevnar 13
|
66.7 percentage of isolates
Interval 57.1 to 75.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype clumps
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
Serotype Missing/non-viable
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
PRIMARY outcome
Timeframe: Surveillance Year 3Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 3 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=111 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:7C
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:9N
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype included in Prevnar 13:3
|
7.2 percentage of isolates
Interval 3.2 to 13.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype included in Prevnar 13:7F
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype included in Prevnar 13:19A
|
9.9 percentage of isolates
Interval 5.1 to 17.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype included in Prevnar 13:19F
|
6.3 percentage of isolates
Interval 2.6 to 12.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Total Serotype included in Prevnar 13
|
23.4 percentage of isolates
Interval 15.9 to 32.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:6C
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:10
|
2.7 percentage of isolates
Interval 0.6 to 7.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:11
|
3.6 percentage of isolates
Interval 1.0 to 9.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:12
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:12F
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:13
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:15A
|
6.3 percentage of isolates
Interval 2.6 to 12.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:15B
|
5.4 percentage of isolates
Interval 2.0 to 11.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:15C
|
5.4 percentage of isolates
Interval 2.0 to 11.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:15F
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:16
|
5.4 percentage of isolates
Interval 2.0 to 11.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:17
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:20
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:21
|
5.4 percentage of isolates
Interval 2.0 to 11.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:22F
|
2.7 percentage of isolates
Interval 0.6 to 7.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:23A
|
2.7 percentage of isolates
Interval 0.6 to 7.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:23B
|
8.1 percentage of isolates
Interval 3.8 to 14.8
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:31
|
4.5 percentage of isolates
Interval 1.5 to 10.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:33A
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:33F
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:34
|
0.9 percentage of isolates
Interval 0.0 to 4.9
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:35B
|
10.8 percentage of isolates
Interval 5.7 to 18.1
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:35F
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype not included in Prevnar 13:38
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Total Serotype not included in Prevnar 13
|
74.8 percentage of isolates
Interval 65.6 to 82.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype clumps
|
0.0 percentage of isolates
Interval 0.0 to 3.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
Serotype Missing/non-viable
|
1.8 percentage of isolates
Interval 0.2 to 6.4
|
PRIMARY outcome
Timeframe: Surveillance Year 1Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 1 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=18 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype included in Prevnar 13:3
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Total Serotype not included in Prevnar 13
|
50.0 percentage of isolates
Interval 26.0 to 74.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype included in Prevnar 13:1
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype included in Prevnar 13:7F
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype included in Prevnar 13:14
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype included in Prevnar 13:19A
|
38.9 percentage of isolates
Interval 17.3 to 64.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype included in Prevnar 13:19F
|
11.1 percentage of isolates
Interval 1.4 to 34.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Total Serotype included in Prevnar 13
|
50.0 percentage of isolates
Interval 26.0 to 74.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:6C
|
5.6 percentage of isolates
Interval 0.1 to 27.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:12
|
5.6 percentage of isolates
Interval 0.1 to 27.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:15A
|
5.6 percentage of isolates
Interval 0.1 to 27.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:15B
|
5.6 percentage of isolates
Interval 0.1 to 27.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:15F
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:21
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:22F
|
11.1 percentage of isolates
Interval 1.4 to 34.7
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:23A
|
5.6 percentage of isolates
Interval 0.1 to 27.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:33F
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:35B
|
5.6 percentage of isolates
Interval 0.1 to 27.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype not included in Prevnar 13:38
|
5.6 percentage of isolates
Interval 0.1 to 27.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
Serotype missing/non-viable
|
0.0 percentage of isolates
Interval 0.0 to 18.5
|
PRIMARY outcome
Timeframe: Surveillance Year 2Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 2 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=7 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype included in Prevnar 13:3
|
28.6 percentage of isolates
Interval 3.7 to 71.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype included in Prevnar 13:7F
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype included in Prevnar 13:1
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype included in Prevnar 13:14
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype included in Prevnar 13:19A
|
71.4 percentage of isolates
Interval 29.0 to 96.3
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype included in Prevnar 13:19F
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Total Serotype included in Prevnar 13
|
100.0 percentage of isolates
Interval 59.0 to 100.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:6C
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:12
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:15A
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:15B
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:15F
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:21
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:22F
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:23A
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:33F
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:35B
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype not included in Prevnar 13:38
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Total Serotype not included in Prevnar 13
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
Serotype missing/non-viable
|
0.0 percentage of isolates
Interval 0.0 to 41.0
|
PRIMARY outcome
Timeframe: Surveillance Year 3Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 3 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=9 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype included in Prevnar 13:1
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype included in Prevnar 13:3
|
44.4 percentage of isolates
Interval 13.7 to 78.8
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype included in Prevnar 13:7F
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype included in Prevnar 13:14
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype included in Prevnar 13:19A
|
11.1 percentage of isolates
Interval 0.3 to 48.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype included in Prevnar 13:19F
|
11.1 percentage of isolates
Interval 0.3 to 48.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Total Serotype included in Prevnar 13
|
66.7 percentage of isolates
Interval 29.9 to 92.5
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:6C
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:12
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:15A
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:15B
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:15F
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:21
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:22F
|
11.1 percentage of isolates
Interval 0.3 to 48.2
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:23A
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:33F
|
22.2 percentage of isolates
Interval 2.8 to 60.0
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:35B
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype not included in Prevnar 13:38
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Total Serotype not included in Prevnar 13
|
33.3 percentage of isolates
Interval 7.5 to 70.1
|
|
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
Serotype missing/non-viable
|
0.0 percentage of isolates
Interval 0.0 to 33.6
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed = number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for amoxicillin from MEF samples was categorized as resistant, susceptible or intermediate based on minimum inhibitory concentration (MIC) for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:I
|
5.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for cefotaxime from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:S
|
5.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:I
|
7.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:I
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and n=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for ceftriaxone from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:I
|
7.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:S
|
6.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:S
|
13.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:S
|
9.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:S
|
11.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:S
|
8.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:S
|
9.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:I
|
8.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:S
|
5.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:S
|
6.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:S
|
3.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:S
|
3.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:S
|
4.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:S
|
3.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:S
|
20.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:S
|
0.7 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for clindamycin from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:S
|
4.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:S
|
5.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:S
|
9.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:S
|
7.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:S
|
4.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:I
|
5.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:I1
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:R
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:R
|
12.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:R
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:R
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for erythromycin from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19A, 19F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:S
|
5.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:S
|
4.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:S
|
9.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:I
|
14.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:I
|
12.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:R
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:R
|
14.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:R
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:R
|
4.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:R
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:R
|
9.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:R
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:R
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples, however, actual 'N' for this OM is unknown as these data were not calculated as per planned analysis. number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for penicillin from MEF samples were summarized by providing the range of MICs for penicillin tested and the percentage of the susceptibility interpretation was categorized as resistant, susceptible or intermediate for each serotype, and for each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95 % CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:S
|
8.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:S
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:S
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:S
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:I
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:I
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:S
|
5.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:S
|
3.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:S
|
3.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:I
|
3.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:I
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:I
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:I
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:I
|
5.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:I
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:I
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:I
|
9.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:I
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:R
|
25.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:R
|
18.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:R
|
9.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:S
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for TMP/S from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19A, 19F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=135 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:R
|
3.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:R
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:S
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:S
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:S
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:S
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:S
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:S
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:S
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:S
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:I
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:I
|
14.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 1:I
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:I
|
12.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:I
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:I
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:I
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 1:R
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 1:R
|
4.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 1:R
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 1:R
|
3.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 1:R
|
15.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 1:R
|
2.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 1:R
|
1.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 1:R
|
0.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 1:R
|
5.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 2:R
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 2:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 2:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 2:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 2:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 2:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 2:R
|
8.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 2:R
|
4.5 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 2:R
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 2:R
|
5.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 2:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 2:R
|
9.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 2:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 3 at Year 3:R
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 6C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 7C at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 9N at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 10 at Year 3:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 11 at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 12F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 13 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15A at Year 3:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15B at Year 3:R
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15C at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 16 at Year 3:R
|
3.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 17 at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19A at Year 3:R
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 19F at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 20 at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 21 at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23A at Year 3:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 23B at Year 3:R
|
6.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 31 at Year 3:R
|
2.7 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 33F at Year 3:R
|
1.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 34 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35B at Year 3:R
|
9.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 35F at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype 38 at Year 3:R
|
0.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype clumps at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Serotype Missing/non-viable at Year 3:R
|
1.8 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for ceftriaxone from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=29 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 1:S
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 1:S
|
27.8 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 1:S
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 2:S
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 2:S
|
57.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 3:S
|
44.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 3:S
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 3 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19A at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 19F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for clindamycin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=29 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 2:S
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 2:S
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 3:S
|
22.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 3:S
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 1:I
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 2:I
|
14.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 1:R
|
22.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19A at Year 2:R
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 3 at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 19F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 12 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Serotype 15B at Year 1:S
|
5.6 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for erythromycin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=29 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 1:I
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 2:R
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 2:S
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 3:S
|
33.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 1:S
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 2:S
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 2:I
|
14.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 3:I
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 1:R
|
22.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 3 at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19A at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 19F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for penicillin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=29 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 1:S
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 2:S
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 2:S
|
14.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 3:S
|
44.4 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 3:S
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 1:R
|
33.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 3 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 2:R
|
57.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 19A at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
Antimicrobial susceptibility of S pneumoniae isolates for TMP/S from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Outcome measures
| Measure |
MEF Population
n=29 Isolates
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 3:I
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 1:R
|
22.2 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 1:S
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 1:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 2:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 3:S
|
33.3 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 3:S
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 1:I
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 1:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 2:I
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 2:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 3:I
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 1:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 1:R
|
5.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 2:R
|
28.6 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 2:R
|
42.9 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 38 at Year 2:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 3 at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 12 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15A at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15B at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 15F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19A at Year 3:R
|
11.1 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 19F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 21 at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 22F at Year 3:R
|
0.0 percentage of isolates
|
|
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Serotype 23A at Year 3:R
|
0.0 percentage of isolates
|
SECONDARY outcome
Timeframe: Baseline Year 1, 2, 3; Surveillance Year 1, 2, 3Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples during baseline (2007-2009) and surveillance (2011-2013) period.N(number of participants analyzed) includes total number of participants in MEF population and n=number of participants for the specified time point.
Percentage of participants with primary diagnosis of otitis media was computed along with exact 2-sided 95% CI based on the observed proportion of participants for each of the 3 surveillance year. Results for baseline period were analyzed for participants who received routinely recommended vaccination of 13vPnC. The cases of otitis media reported during the baseline period were captured by the Texas Children's Hospital, which was the only site that collected this information during the baseline period. Percentage of participants was calculated by dividing number of participants with at least 1 MEF sample for the specified year by total number of participants with at least 1 MEF sample for the 3 year surveillance period.
Outcome measures
| Measure |
MEF Population
n=357 Participants
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Participants With Primary Clinical Diagnosis of Otitis Media
Baseline Year 1: 2007
|
24.0 percentage of participants
Interval 14.9 to 35.3
|
|
Percentage of Participants With Primary Clinical Diagnosis of Otitis Media
Baseline Year 2: 2008
|
45.3 percentage of participants
Interval 33.8 to 57.3
|
|
Percentage of Participants With Primary Clinical Diagnosis of Otitis Media
Baseline Year 3: 2009
|
30.7 percentage of participants
Interval 20.5 to 42.4
|
|
Percentage of Participants With Primary Clinical Diagnosis of Otitis Media
Surveillance Year 1: 2011
|
37.8 percentage of participants
Interval 32.8 to 43.1
|
|
Percentage of Participants With Primary Clinical Diagnosis of Otitis Media
Surveillance Year 2: 2012
|
31.1 percentage of participants
Interval 26.3 to 36.2
|
|
Percentage of Participants With Primary Clinical Diagnosis of Otitis Media
Surveillance Year 3: 2013
|
31.1 percentage of participants
Interval 26.3 to 36.2
|
SECONDARY outcome
Timeframe: Surveillance Year 1, 2, 3Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples surveillance period. N(number of participants analyzed) includes total number of participants in mastoid population.
Percentage of participants with primary diagnosis of mastoiditis was computed along with exact 2-sided 95% CI based on the observed proportion of participants for each of the 3 surveillance year. Percentage of participants was calculated by dividing number of participants with at least 1 mastoid sample for the specified year by total number of participants with at least 1 mastoid sample for the 3 year surveillance period.
Outcome measures
| Measure |
MEF Population
n=34 Participants
Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013.
|
|---|---|
|
Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis
Surveillance Year 1
|
52.9 percentage of participants
Interval 35.1 to 70.2
|
|
Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis
Surveillance Year 2
|
20.6 percentage of participants
Interval 8.7 to 37.9
|
|
Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis
Surveillance Year 3
|
26.5 percentage of participants
Interval 12.9 to 44.4
|
Adverse Events
MEF Population
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Mastoid Population
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
- Publication restrictions are in place
Restriction type: OTHER